Miriam Anand
Allergy & Immunology · Tempe, AZNPI 1407824790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations.
Across 201 payments — averaging $21.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$556
- GSK$457
- Novartis$346
- Sanofi$326
- CSL Behring$293
- Genentech USA, Inc.$279
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,368100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $556 |
| GSK | 24 | $457 |
| Novartis | 18 | $346 |
| Sanofi | 11 | $326 |
| CSL Behring | 15 | $293 |
| Genentech USA, Inc. | 8 | $279 |
| Regeneron Healthcare Solutions, Inc. | 11 | $259 |
| Octapharma USA, Inc. | 3 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $189 |
| Grifols USA, LLC | 9 | $170 |
| Biocryst US Sales Co., LLC | 9 | $169 |
| Pharming Healthcare, Inc. | 9 | $158 |
| Kaleo, Inc. | 5 | $113 |
| Teva Pharmaceuticals USA, Inc. | 8 | $108 |
| Boehringer Ingelheim | 5 | $96 |
| Optinose US, Inc. | 5 | $96 |
| Blueprint Medicines Corporation | 4 | $89 |
| Amgen(2 entities) | 2 | $66 |
| Aerin Medical Inc. | 2 | $54 |
| Phadia US Inc. | 2 | $42 |
| Shire North American Group Inc | 2 | $42 |
| Circassia Inc. | 1 | $39 |
| Covis Pharma GmbH | 2 | $37 |
| Pfizer | 2 | $36 |
| Fresenius Kabi USA, LLC | 1 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $25 |
| Electromed, Inc. | 1 | $22 |
| ADMA Biomanufacturing LLC | 1 | $18 |
| Ionis Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Incyte Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XOLAIR$148
How this compares
$4,386 in reported general payments places this provider in the 60th percentile of 90 allergy & immunology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $97,098 |
| NucalaMepolizumab | 15 | $53,794 |
| Spiriva RespimatTiotropium Bromide | 50 | $46,553 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $27,075 |
| SymbicortBudesonide/Formoterol Fumarate | 63 | $16,936 |
| Arnuity ElliptaFluticasone Furoate | 54 | $16,244 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $15,731 |
| DuleraMometasone/Formoterol | 13 | $8,803 |
| Qvar RedihalerBeclomethasone Dipropionate | 23 | $7,001 |
| Epinephrine | 20 | $3,918 |
| RyaltrisOlopatadine Hcl/Mometasone | 12 | $3,448 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $3,136 |
| Azelastine Hcl | 73 | $2,869 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,115 |
| Montelukast Sodium | 94 | $1,022 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala, Trelegy Ellipta, Arnuity Ellipta, Breo Ellipta | $457 | $112,843132 claims |
| Boehringer IngelheimSpiriva Respimat | $96 | $46,55350 claims |
| AstraZenecaSymbicort | $556 | $16,93663 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $108 | $7,00123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 90 allergy & immunology providers in Arizona.
Other allergy & immunology in Tempe
- Michael ManningScottsdale$1.1M
- Neal JainGilbert$388K
- Jennifer HillScottsdale$335K
- Jean NelsonScottsdale$183K
- Kiranjit KhalsaScottsdale$124K
- Keith SaccoPhoenix$118K
- Jacob MadduxSurprise$87K
- Tara CarrTucson$76K
- Duane WongChandler$43K
- Connie HsuLitchfield Park$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.